An autosomal recessive constitutional mismatch repair deficiency syndrome caused by pathogenic variants in the MLH1 mismatch repair gene. It is characterized by a high risk of childhood cancers, inclu...
Comprehensive, easy-to-understand information about this condition
How we create this content →Report Generation Failed
We couldn't automatically generate the report. This may be due to temporary service issues.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
Organizations with orphan designations or approved therapies for this disease
Amgen Inc
Other
Blaze Bioscience, Inc.
Other
Candel Therapeutics, Inc.
Other
Celgene Corporation
Other
Falk Center for Molecular Therapeutics
Other
Genentech, Inc.
Other
ImmunoGen, Inc.
Other
Novartis Pharmaceuticals Corporation
Other
OSI Pharmaceuticals, Inc.
Other
Oncothyreon Canada, Inc.
Other
Xenova Biomedix Limited
Other